Assessment of Oil and Seed Extracts of Moringa oleifera for Promising Anticandidal Activity in Autistic Children | ||
| Egyptian Journal of Botany | ||
| Article 16, Volume 62, Issue 3, September 2022, Pages 825-835 PDF (1.41 M) | ||
| Document Type: Regular issue (Original Article) | ||
| DOI: 10.21608/ejbo.2022.61779.1624 | ||
| Authors | ||
| Elzawawy Nessma; Metwally A. Metwally; Hegazy Samah* | ||
| Botany Department, Faculty of Science, Tanta University, Tanta, Egypt | ||
| Abstract | ||
| MORINGA OLEIFERA (M. oleifera) is a plant with a high nutritional value and an impressive range of medicinal uses. Plants of the Moringaceae family contain a wide range of secondary metabolites with biological activities, with an essential role in the pharmaceutical industry. To the best of our knowledge, this is the first study to report the anti-candidal, antioxidant properties and chemical constituents of M. oleifera oil and its seed extracts with its in vivo toxicological assessment as herbal medicine. The results showed that M. oleifera oil showed the highest antifungal activity against six strains of Candida species isolated from the stool samples of the autistic children, which included C. albicans, C. dulblinesis, C. glabarata, C. kefyr, C. krusei, and C. lusitania. The M. oleifera oil (1.0%) exhibited the highest growth rate reduction and antioxidant activity. The GC/MS of M. oleifera oil revealed 17 compounds with methyl ester, stigmasterol, tetraphenyl and vitamin E as significant components. Moreover, an in vivo toxicological assessment confirmed the safety of M. oleifera oil. Therefore, M. oleifera oil can serve to be a promising therapy for improving autistic gastrointestinal problems. | ||
| Keywords | ||
| Autistic children; Intestinal candidiasis; Moringa oleifera oil | ||
|
Statistics Article View: 539 PDF Download: 853 |
||
